The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Value Trend Is Expected For The Respiratory Disease Testing Market From 2026 To 2030?
The respiratory disease testing market size has experienced robust growth recently. Forecasts indicate its expansion from $3.74 billion in 2025 to $3.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.3%. Historically, this market’s expansion was driven by several factors, including a rise in chronic respiratory disease cases, enhanced hospital diagnostic facilities, greater understanding of the importance of early disease identification, wider use of spirometry tests, and intensified healthcare screening efforts.
The respiratory disease testing market is projected to undergo significant expansion over the next few years. It is expected to reach $4.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.8%. This anticipated growth during the forecast period is fueled by the escalating demand for quick and precise respiratory diagnostics, increased investments in diagnostic infrastructure, the broadening availability of home-based respiratory testing, the expanding integration of AI-driven diagnostic instruments, and a heightened emphasis on population health management. Noteworthy trends predicted for this period include a greater embrace of early diagnostic testing solutions, an increased utilization of in-vitro diagnostic respiratory tests, the growing incorporation of digital pulmonary monitoring tools, the widespread implementation of point-of-care respiratory testing, and a stronger focus on preventive respiratory care.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10304&type=smp
What Are The Main Drivers Accelerating The Growth Of The Respiratory Disease Testing Market?
An increase in respiratory illnesses is projected to fuel growth in the respiratory disease testing market. Respiratory diseases are defined as health issues impacting the respiratory system, encompassing organs like the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The main purpose of respiratory disease testing is the early identification and diagnosis of these conditions, enabling prompt treatment and management. Such testing aids in preventing disease progression and is crucial for managing the spread of contagious respiratory illnesses while minimizing complications. For example, data from June 2025 by the Office for Health Improvement and Disparities (OHID), a UK government body, indicated a 7% rise in emergency admissions for respiratory disease in England between the financial year ending 2023 and the financial year ending 2024. Consequently, the growing occurrence of respiratory diseases is a key factor propelling the respiratory disease testing market.
Which Segment Divisions Form The Structure Of The Respiratory Disease Testing Market?
The respiratory disease testing market covered in this report is segmented –
1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests
2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products
3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Applications
4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-Users
Subsegments:
1) By Imaging Tests: X-rays, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans
2) By Mechanical Tests: Spirometry, Peak Flow Measurement, Lung Volume Measurement, Diffusion Capacity Tests
3) By In-Vitro Diagnostic Tests: PCR Tests, Antigen Tests, Antibody Tests, Culture Tests
What Trends Are Influencing The Respiratory Disease Testing Market Outlook?
Major companies active in the resorbable vascular scaffolds market are developing magnesium scaffolds to enhance biocompatibility and offer superior mechanical support. Magnesium scaffolds facilitate natural vessel healing while concurrently reducing inflammation and complications often linked with traditional polymer-based scaffolds. For instance, in March 2024, Biotronik, a Germany-based medical device company, secured Food and Drug Administration (FDA) breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). The Freesolve RMS is an innovative device tailored for individuals with chronic limb-threatening ischemia (CLTI), presenting an advanced therapeutic choice for below-the-knee (BTK) procedures. It incorporates BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology, which collectively improve safety, deliverability, and vessel support. This scaffold provides temporary support to prevent vessel recoil during the healing period.
Which Industry Players Are Present In The Respiratory Disease Testing Market?
Major companies operating in the respiratory disease testing market are Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc.
Access The Complete Respiratory Disease Testing Market Report:
https://www.thebusinessresearchcompany.com/report/respiratory-disease-testing-global-market-report
What Is The Largest Regional Market In The Respiratory Disease Testing Market?
North America was the largest region in the respiratory disease testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Respiratory Disease Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=10304&type=smp
Browse Through More Reports Similar to the Global Respiratory Disease Testing Market 2026, By The Business Research Company
Vertebroplasty Needles Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vertebroplasty-needles-global-market-report
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Bioresorbable Medical Material Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model